US Earnings Financial Results SEC Filings — October 29, 2026

29-10-2026

Crocs, Inc. reported Q3 2026 revenue of $1,042.6M, up 4.6% YoY from $996.3M, with net income of $216.8M (up 48.6% YoY) and diluted EPS of $4.52 (up from $2.70). Nine-month revenue rose 1.9% to $3,143.5M, and net income swung to $559.2M from a $186.4M loss a year earlier, which was driven by prior-year goodwill and asset impairments. However, Q3 SG&A grew 6.0% YoY, interest expense declined only modestly, and the company continued aggressive buybacks that drove treasury stock up to $3,564.4M and total stockholders' equity up only 4.0% YTD to $1,345.0M.

• · Interest expense fell to $19.1M in Q3 2026 from $21.7M, and nine-month interest expense declined to $59.4M from $67.0M, reflecting lower debt costs.
• · Long-term borrowings rose to $1,289.0M from $1,230.9M at year-end, funding buybacks despite the company's stated cash-generating profile.
• · Income taxes payable (long-term) of $641.6M remain a large liability, while deferred tax assets of $904.8M are a significant balance-sheet item.
• · Accumulated other comprehensive loss widened to $(65.0)M from $(43.7)M at year-end, driven by foreign currency translation losses of $(22.1)M YTD.
• · Accounts receivable grew to $355.0M from $278.2M at year-end (+27.6%), outpacing nine-month revenue growth of 1.9%, a potential working-capital flag.
• · Inventories increased to $413.0M from $368.7M at year-end (+12.0%), again outpacing revenue growth.
• · Net cash provided by financing activities was negative $472.5M, reflecting $506.2M in buybacks partially offset by net borrowings of $51.0M.

29-10-2026

Preformed Line Products (PLPC) reported Q3 2026 net sales of $209.5M, up 17.7% YoY from $178.1M, with net income attributable to shareholders of $18.0M versus $2.6M a year earlier (the prior-year quarter included an $11.7M pension termination expense). Growth was not uniform: Asia-Pacific Special Industries and Communications sales mix weakened, and Communications as a share of consolidated sales fell from 23% to 19%, while Energy rose to 75% of sales.

• · Q3 2026 diluted EPS was $3.56 versus $0.53 in Q3 2025; nine-month diluted EPS was $10.18 versus $5.42.
• · Q3 2026 Asia-Pacific Communications share stayed at 2% and Asia-Pacific Special Industries share fell from 25% to 21%, while PLP-USA Communications share dropped from 34% to 28%.
• · Q3 2026 foreign currency translation was a $1.2M loss in other comprehensive income, versus a $1.7M gain a year earlier.
• · Q3 2026 effective tax expense was about 29.5% of pre-tax income ($7.5M on $25.6M), versus a tax benefit in Q3 2025.
• · Allowance for credit losses rose to $6.9M at September 30, 2026 from $5.8M at December 31, 2025, with $1.0M of additions in the nine months.
• · Inventories rose to $183.3M from $168.0M at December 31, 2025, with raw materials up to $106.6M from $96.0M.
• · Nine-month 2026 financing cash flow was roughly neutral (-$0.4M), with $21.7M of new long-term debt offsetting $11.4M of related-party share purchases and $4.4M of debt repayments.

29-10-2026

Albany International Corp. (AIN) reported Q3 2026 net revenues of $349.5M, up 33.7% YoY from $261.4M, with net income attributable to the Company of $41.7M versus a $97.8M loss in Q3 2025, and diluted EPS of $1.46 versus $(3.37). Nine-month net revenues rose 14.9% to $990.4M, but nine-month results remain mixed: the Engineered Composites (AEC) segment drove the quarterly rebound while the Machine Clothing (MC) segment's revenue declined 2.9% YoY to $169.8M, and cash and cash equivalents fell to $79.1M from $112.4M at year-end 2025.

• · Q3 2026 AEC segment operating income was $43.3M versus an operating loss of $(148.0)M in Q3 2025, reflecting a prior-year charge tied to contract loss provisions.
• · Nine-month 2026 contract loss provision recovery of $(52.5)M contrasts with a $139.7M provision in nine-month 2025, a major driver of the swing to positive operating income.
• · Long-term debt declined to $422.1M from $455.7M at year-end 2025, with nine-month net repayments of $30.0M.
• · Assets held for sale of $293.8M and liabilities held for sale of $203.3M at December 31, 2025 were fully eliminated by September 30, 2026, indicating a completed divestiture.
• · Nine-month 2025 included a $170.96M share repurchase that did not recur in 2026; 2026 treasury stock was essentially unchanged.
• · Inventories rose 36.2% to $165.5M and contract assets rose 88.8% to $164.4M since year-end 2025, tying up working capital.
• · Q3 2026 MC segment restructuring expenses were $6.8M, indicating continued restructuring within the Machine Clothing business.

29-10-2026

Belden reported Q3 2026 revenues of $965.954 Million, up 38.3% YoY from $698.221 Million, driven by the newly acquired Wireless segment ($167.799 Million) and growth in Smart Buildings (+22.6%) and Automation (+16.5%). However, the company swung to a net loss of $(11.351) Million versus net income of $56.690 Million in the prior-year quarter, as operating income fell 78.0% to $16.764 Million amid sharply higher SG&A, amortization of intangibles, and interest expense. Broadband revenue was essentially flat (+1.8%), and nine-month net income declined 36.2% to $108.212 Million.

• · Q3 2026 gross margin expanded to roughly 35.1% (338.750/965.954) from 37.7% in Q3 2025, a contraction of about 2.6 points.
• · Q3 2026 income tax was a benefit of $14.183M on a pre-tax loss, versus a $7.562M expense in Q3 2025.
• · Cash from business acquisitions of $1,869.631M and $2,432.630M of credit borrowings in nine months 2026 materially increased leverage; interest expense rose sharply as a result.
• · Debt issuance costs of $47.545M were paid in nine months 2026 versus $3.178M in the prior year.
• · Price adjustments recognized against gross receivables rose to $131.299M from $33.258M at year-end 2025, and accrued returns rose to $35.229M from $11.892M, signaling elevated customer-related adjustments.
• · Nine-month 2026 cash flow from investing was $(2,002.387)M versus $(89.122)M in 2025; cash used for share repurchases fell to $31.806M from $150.967M.
• · Diluted weighted shares declined to 39.374M (nine months) from 40.324M, reflecting ongoing buybacks.
• · Contract liabilities jumped to $250.607M at Q3 2026, driven by $201.675M acquired, with new deferrals of $57.818M in the quarter.

29-10-2026

GPO Plus reported Q1 FY2027 (quarter ended July 31, 2026) revenue of $1,295,507, essentially flat versus $1,302,172 a year earlier (-0.5% YoY), while gross profit fell 20.8% to $298,163 as cost of revenue rose 7.7% to $997,344, compressing gross margin. Net loss widened 12.9% to $784,715 from $694,843, driven by higher interest expense (+17.5% to $316,700), though total operating expenses declined 4.2% to $766,448. The company remains deeply insolvent with a stockholders' deficit of $8,855,126 and total liabilities of $7,447,656 against total assets of just $509,684.

• · Gross margin compressed to approximately 23.0% in Q1 FY2027 from 28.9% in Q1 FY2026
• · Total liabilities of $7,447,656 exceed total assets of $509,684, producing a stockholders' deficit of $8,855,126
• · Accumulated deficit deepened to $46,980,971 from $46,196,256 at April 30, 2026
• · Promissory note payable (net of $95,258 discount) rose to $4,011,616 from $3,747,081
• · Accrued interest climbed to $739,968 from $551,996
• · Net cash used in operating activities improved to $358,803 from $434,234
• · Financing activities provided $407,507, including $430,100 of promissory note proceeds
• · Company issued 4,968,639 common shares for promissory note repayment ($215,922) and 500,000 shares for loan inducement ($30,060)
• · Cash rose to $56,210 from $7,506 at fiscal year-end
• · Management fees and salaries to related parties fell to $35,367 from $59,282
• · Professional fees stock-based compensation increased to $121,099 from $85,225
• · Net loss per share remained $(0.01) basic and diluted

29-10-2026

TechnipFMC reported Q3 2026 revenue of $2,895.8M, up 9.4% YoY from $2,647.3M, with net income attributable to the company rising 35.1% to $418.4M and diluted EPS up 40% to $1.05. Subsea revenue grew 12.1% to $2,600.0M on strength in Latin America (+26.7%) and Middle East (+109.1%), however Surface Technologies revenue declined 9.8% to $295.8M with weakness in Africa (-32.0%) and Middle East (-17.6%). Nine-month operating cash flow improved to $1,411.2M from $1,311.0M, while share repurchases increased to $1,004.9M from $750.2M, reducing share count and driving EPS growth.

• · Service revenue rose 8.1% YoY to $1,770.9M while product revenue rose 11.5% YoY to $1,124.9M in Q3 2026
• · Research and development expense increased 33.8% YoY to $30.1M in Q3 2026
• · Restructuring, impairment and other expenses fell to $0.5M in Q3 2026 from $3.1M a year earlier
• · Interest expense declined to $12.4M in Q3 2026 from $18.9M, reflecting lower debt levels
• · Nine-month 2026 other comprehensive income was $3.6M versus $346.6M in 2025, driven by a $231.3M FX translation gain in the prior year
• · Total debt fell to $404.0M at September 30, 2026 from $430.0M at December 31, 2025
• · Contract liabilities rose to $2,241.1M from $2,148.9M at year-end 2025, while trade receivables and contract assets increased $524.3M in the nine months
• · Effective tax rate rose to 19.9% in Q3 2026 from 19.7% in Q3 2025
• · Ordinary shares outstanding declined to 389.9M from 400.7M at December 31, 2025 due to buybacks

29-10-2026

Gen Digital reported Q2 FY2027 net revenue of $1,369M, up 12.2% YoY from $1,220M, with net income more than doubling to $287M from $134M and diluted EPS rising to $0.48 from $0.21. Operating income improved 15.8% to $507M, helped by lower interest expense ($123M vs $146M) and a swing in other income to $2M from a $59M expense. However, gross margin compressed as cost of revenues jumped 24.1% to $330M (gross profit up only 8.9%), R&D rose 12% and G&A rose 10%, while restructuring costs fell to zero in the quarter versus $4M a year ago.

• · Gross margin compressed: gross profit grew only 8.9% while revenue grew 12.2%, as cost of revenues rose 24.1% to $330M.
• · Six-month restructuring and other costs rose to $32M from $14M YoY, though Q2 restructuring was zero versus $4M last year.
• · Sales and marketing was essentially flat at $298M vs $297M (+0.3%).
• · Long-term debt declined to $7,036M from $8,015M, but current portion of long-term debt jumped to $1,080M from $181M, shifting $899M into near-term maturities.
• · Cash and equivalents rose to $589M from $411M; total assets were roughly flat at $15,548M vs $15,589M.
• · Goodwill declined slightly to $10,930M from $10,996M and intangibles fell to $1,927M from $2,096M.
• · Company repurchased $173M of stock in Q2 and $273M in six months; declared $0.125/share quarterly dividend ($78M in Q2).
• · Diluted weighted-average shares fell to 603M from 624M YoY, supporting EPS growth.
• · Six-month income tax expense fell to $207M from $264M despite higher pre-tax income.

29-10-2026

Ecolab reported Q3 2026 net sales of $4,694.8M, up 12.7% YoY from $4,165.0M, with operating income rising 6.6% to $810.5M. However, net income attributable to Ecolab declined 5.8% YoY to $551.3M and diluted EPS fell 4.9% to $1.95, driven by a sharp 125.7% jump in net interest expense to $124.8M and higher special charges of $81.4M versus $26.2M. For the nine-month period, sales grew 10.9% to $13,176.3M and net income edged up 0.5% to $1,518.8M, while the balance sheet expanded significantly with goodwill up to $12,687.6M and long-term debt rising to $11,915.3M following $4,683.1M of acquisitions.

• · Product and equipment sales rose 13.3% YoY to $3,697.4M while service and lease sales grew 10.5% to $997.4M in Q3 2026.
• · Cost of sales increased 14.2% YoY to $2,625.5M in Q3 2026, outpacing sales growth and pressuring gross margin.
• · SG&A expenses rose 9.1% YoY to $1,177.4M in Q3 2026.
• · Nine-month 2026 cash provided by operating activities was $1,939.1M versus $1,862.5M in 2025.
• · Nine-month 2026 investing activities used $5,621.1M, largely due to $4,683.1M of acquisitions, versus $729.0M used in 2025.
• · Financing activities provided $3,755.0M in nine-month 2026, driven by $5,104.9M of long-term debt borrowings, versus $421.7M used in 2025.
• · Total assets grew to $31,107.9M from $24,696.3M at December 31, 2025, with other intangible assets rising to $5,098.5M from $3,688.5M.
• · Accounts receivable increased to $3,795.4M from $3,249.4M and inventories rose to $1,764.8M from $1,490.4M.
• · Q3 2026 comprehensive income attributable to Ecolab fell to $517.2M from $684.4M, reflecting a $39.5M foreign currency translation loss versus a $101.5M gain in Q3 2025.
• · Nine-month 2026 dividends declared were $615.5M versus $552.9M in 2025; treasury stock rose to $9,749.9M from $9,079.6M.
• · Acquisition and integration special charges were $42.2M in Q3 2026 versus $11.0M in Q3 2025.

29-10-2026

Incyte reported Q3 2026 total revenues of $1,557.2M, up 14.0% YoY from $1,366.0M, driven by net sales of $1,316.4M (+14.5%) and product royalties of $191.0M (+11.6%). However, R&D expense surged to $1,791.7M from $506.6M, producing an operating loss of $708.4M and a net loss of $784.8M (diluted EPS -$3.86) versus net income of $424.2M ($2.11) a year earlier. For the nine months, revenue rose 23.9% to $4,503.9M but net income fell 89.5% to $104.1M, with ICLUSIG (-10.8% YoY) and PEMAZYRE (-6.9% YoY) declining in Q3 while OPZELURA (+35.6%), NIKTIMVO (+47.0%) and ZYNYZ (+157.2%) grew strongly.

• · Diluted EPS swung to -$3.86 in Q3 2026 from $2.11 in Q3 2025; nine-month diluted EPS fell to $0.50 from $4.95
• · Milestone and contract revenues rose to $49.8M in Q3 2026 from $45.0M, and to $78.0M for nine months from $50.0M
• · Selling, general and administrative expense increased 10.7% YoY to $364.3M in Q3 2026
• · Asset impairment and related disposal costs of $23.2M recorded in nine months 2026 (none in prior year)
• · Nine-month 2025 results included a $242.3M contract dispute settlement benefit (no comparable item in 2026)
• · Deferred income tax asset declined to $281.7M from $515.3M at December 31, 2025
• · Retained earnings rose to $317.9M from $213.8M at year-end 2025; total stockholders' equity increased to $5,642.9M from $5,167.5M
• · Nine-month 2026 net cash used in investing activities was $184.3M versus $65.2M prior year; financing activities provided $164.2M versus $36.7M used

29-10-2026

Thunder Bridge Capital Partners V, Ltd. filed its first 10-Q for the quarter ended September 30, 2026, reflecting its IPO completed during the period: it raised $294,930,000 in gross unit proceeds plus $7,470,000 from private placement units, with $300,150,000 placed into the Trust Account (balance $301,502,927). The company posted Q3 2026 net income of $1,057,015 (vs. $0 in Q3 2025) driven entirely by $1,352,927 of trust interest income, while formation and G&A costs rose to $297,713 from nil, and nine-month net income was $978,739 versus a $3,850 loss in 2025. However, the balance sheet shows a shareholders' deficit of $11,061,259 (accumulated deficit $11,062,084) and total liabilities of $12,871,588, including a $12,789,000 deferred underwriting fee payable, with no business combination target yet identified.

• · No business combination target has been identified; company remains a blank-check SPAC.
• · Class A ordinary shares subject to possible redemption: 30,015,000 shares at $10.03 per share.
• · Class B ordinary shares outstanding rose to 7,503,750 from 1, including 7,503,750 issued to Sponsor in exchange for settlement of $25,000 advances.
• · Deferred underwriting fee payable of $12,789,000 is the largest liability.
• · Net cash used in operating activities was $593,420 for the nine months ended September 30, 2026.
• · Accretion for Class A shares to redemption amount totaled $22,776,359, driving the accumulated deficit.
• · Basic and diluted net income per Class A share was $0.05 and $0.04 respectively in Q3 2026; nine-month EPS was $0.11.
• · Offering costs allocated to Public Warrants and Private Placement Units were $289,394; accrued offering costs of $75,000 remain unpaid.

29-10-2026

Norwegian Cruise Line Holdings reported Q3 2026 total revenue of $2,946,763 thousand, essentially flat (+0.3%) versus $2,938,142 thousand in Q3 2025, as passenger ticket revenue declined 5.1% to $1,945,639 thousand while onboard and other revenue grew 12.7% to $1,001,124 thousand. Operating income fell 16.7% to $624,274 thousand on higher fuel (+11.3%), payroll (+9.8%) and depreciation (+14.7%) costs, but net income rose 17.2% to $491,465 thousand and diluted EPS improved to $1.07 from $0.86, helped by a 48.1% reduction in net interest expense to $170,544 thousand. For the nine months, revenue grew 4.4% to $7,918,528 thousand and net income more than doubled to $818,684 thousand, though operating income declined 11.2% to $1,220,544 thousand.

• · Total cruise operating expense rose 7.3% YoY to $1,667,668 thousand in Q3 2026 from $1,554,859 thousand.
• · Marketing, general and administrative expense declined 4.1% YoY to $367,118 thousand in Q3 2026.
• · Advance ticket sales (customer deposits) fell to $3,141,976 thousand at September 30, 2026 from $3,200,593 thousand at December 31, 2025.
• · Nine-month 2026 net cash provided by operating activities was $1,706,360 thousand versus $1,630,636 thousand in 2025.
• · Capital expenditures (additions to property and equipment) declined to $2,292,043 thousand in 9M 2026 from $2,821,959 thousand in 9M 2025.
• · Total debt repayments of $1,894,036 thousand and new borrowings of $2,487,283 thousand occurred in 9M 2026, versus $7,723,694 thousand repaid and $9,225,819 thousand borrowed in 9M 2025.
• · Accumulated deficit narrowed to $4,747,950 thousand from $5,566,634 thousand at December 31, 2025.
• · Diluted weighted-average shares fell to 460,423,326 in Q3 2026 from 495,727,378 in Q3 2025, boosting diluted EPS.
• · Income tax was a $6,834 thousand benefit in Q3 2026 versus $14,341 thousand expense in Q3 2025.
• · Proceeds from sale of ships of $104,995 thousand recorded in 9M 2026.

29-10-2026

California Water Service Group reported Q3 2026 operating revenue of $332.2M, up 6.7% YoY from $311.2M, with net income attributable to the company rising 6.8% to $65.4M and diluted EPS of $1.05 vs $1.03. However, net other income fell sharply to $1.7M from $7.6M YoY on higher non-regulated expenses ($9.1M vs $2.5M) and lower pension credits, while industrial revenue declined 29.8% to $7.8M. Nine-month revenue grew 9.6% to $855.3M and net income rose 7.9% to $125.9M, though net other income dropped to $11.4M from $20.9M and interest expense climbed 16.3%.

• · Residential revenue rose 5.3% YoY to $196.5M in Q3 2026; business revenue up 9.0% to $61.3M
• · Water production costs declined slightly to $102.1M from $102.7M in Q3 2026
• · Other operations expense jumped 12.1% YoY to $37.5M in Q3 2026
• · Income tax expense rose to $17.7M from $10.6M in Q3 2026
• · Nine-month net cash from operations was $262.2M vs $254.7M prior year
• · Utility plant expenditures rose to $424.8M from $364.7M in nine-month period
• · Short-term borrowings increased to $175.0M from $130.0M at year-end 2025
• · Common shares outstanding grew to 62,877 thousand from 59,638 thousand at Dec 31, 2025

29-10-2026

Cimpress reported Q1 FY27 revenue of $934.1M, up 8.2% YoY from $863.3M, but swung to a net loss of $2.7M (EPS -$0.11) from net income of $7.6M ($0.30 diluted) a year ago as cost of revenue jumped 14.2% and gross margin compressed. Income from operations fell 46.9% to $26.0M, with restructuring expense rising to $4.0M from $0.3M and G&A up 17.0%, while interest expense eased to $26.3M. Cash fell $128.7M to $120.1M, driven by $131.6M of business acquisitions and a $22.8M capex spend, partly offset by $28.9M of operating cash flow.

• · Gross margin compressed: cost of revenue rose 14.2% vs revenue growth of 8.2%, implying gross profit of $408.2M vs $402.8M prior year
• · Diluted weighted average shares fell to 24,484,986 from 25,051,742, and the diluted share count equals basic due to the net loss
• · Assets held for sale of $46.3M appeared on the balance sheet at September 30, 2026 (none at June 30, 2026)
• · Goodwill rose to $882.6M from $850.8M and intangibles to $87.9M from $70.6M, reflecting acquisitions
• · Short-term debt increased to $49.5M from $14.6M; long-term debt roughly flat at $1,594.7M
• · Share-based compensation expense rose to $16.1M from $14.8M; withholding tax payments on equity awards jumped to $13.8M from $6.7M
• · Net cash used in investing activities was $169.1M vs $42.8M prior year, driven by acquisitions and capex
• · Foreign currency translation losses widened to $4.5M from $0.5M, driving comprehensive loss of $5.6M attributable to Cimpress
• · Total shareholders' deficit widened to -$499.3M from -$494.0M
• · Accounts payable fell to $304.8M from $333.3M while accrued expenses rose to $351.0M from $324.7M

29-10-2026

OSI Systems reported Q1 FY2027 (three months ended September 30, 2026) revenue of $403.472M, up 4.9% YoY from $384.623M, with net income rising 19.5% to $24.572M and diluted EPS up 28.0% to $1.51 from $1.18. However, gross margin compressed to 30.7% from 32.0% as cost of goods sold grew 7.0% faster than revenue, and operating income was roughly flat at $33.570M (+1.5%) as total operating expenses held steady. Cash and equivalents fell $123.534M to $236.298M, driven by $65.508M of short-term investment purchases and $62.845M of share repurchases, while inventories rose 11.5% to $463.367M.

• · Interest and other expense, net fell to $3.321M from $7.398M YoY, a key driver of net income growth beyond operations
• · Income tax provision rose to $5.677M from $5.119M; cash income taxes paid jumped to $16.254M from $9.609M
• · Selling, general and administrative expense rose 2.6% to $68.709M while R&D fell 4.9% to $19.426M
• · Restructuring and other charges declined to $2.096M from $2.730M
• · Accounts payable rose to $190.268M from $168.981M and advances from customers increased to $64.099M from $42.391M
• · Total stockholders' equity declined to $782.844M from $832.961M, reflecting $72.266M of retained earnings used for buybacks
• · 46 thousand shares were excluded from diluted EPS due to anti-dilutive effect, versus none in the prior year
• · Foreign currency translation adjustment was a $2.297M loss versus $0.161M prior year

29-10-2026

Chipotle reported Q3 2026 total revenue of $3,293.2M, up 9.6% YoY from $3,003.4M, with food and beverage revenue up 9.6% to $3,277.9M. However, income from operations fell 5.3% YoY to $452.0M, net income declined 11.0% to $339.9M, and diluted EPS fell to $0.27 from $0.29, as labor, other operating costs, and G&A grew faster than revenue. Nine-month net income declined 13.1% to $1,046.2M, and retained earnings dropped sharply to $154.5M from $619.9M at year-end 2025 following $1.46B in buybacks.

• · Labor costs rose 12.0% YoY in Q3, outpacing 9.6% revenue growth, and rose from 25.2% to 25.7% of revenue
• · Other operating costs rose 16.7% YoY in Q3, from 15.0% to 16.0% of revenue
• · G&A expenses rose 26.2% YoY in Q3 to $185.2M, increasing as a share of revenue from 4.9% to 5.6%
• · Interest and other income fell 77.5% YoY in Q3 to $5.2M from $19.8M, reflecting lower investment balances (current investments fell to $268.4M from $698.6M)
• · Effective tax rate was 25.6% in Q3 2026 vs 23.1% in Q3 2025
• · Nine-month operating cash flow rose 13.9% to $1,922.1M, while capex rose 36.7% to $640.6M
• · Total shareholders' equity declined to $2,455.1M from $2,830.6M at year-end 2025 due to buybacks exceeding retained earnings
• · Income taxes paid fell to $102.6M from $319.0M, including a $93.0M purchase of federal transferable energy credits
• · Chipotle Rewards liability rose 41.5% from Dec 31, 2025 to $90.2M, and deferred revenue from gift cards was largely recognized ($80.7M for nine months)
• · Level 3 fair value assets total $29.2M, including corporate debt and notes receivable

29-10-2026

Phathom Pharmaceuticals reported Q3 2026 product revenue, net of $84.7M (in thousands: $84,722K), up 71% year-over-year from $49.5M, and nine-month product revenue of $217.3M, up 85% from $117.5M. Net loss narrowed sharply to $13.9M for the quarter (vs. $30.0M in Q3 2025) and $61.8M for the nine months (vs. $200.1M), while stockholders' deficit improved to $347.6M from $438.2M at year-end 2025. However, selling, general and administrative expense rose 12% in the quarter to $57.7M, cost of revenue nearly tripled to $18.4M, and loss from operations was essentially breakeven at $(0.085)M, and accrued revenue allowances and accounts receivable grew, and total liabilities remain high at $692.7M.

• · Loss from operations narrowed to near breakeven at $(0.085)M in Q3 2026 vs. $(15.3)M in Q3 2025, but nine-month operating loss of $(19.5)M is still meaningfully negative.
• · Cost of revenue rose about 197% YoY in Q3 to $18.4M, growing much faster than product revenue (71%), compressing the gross margin percentage from roughly 87.5% to 78.3%.
• · Research and development expense rose 24% YoY in Q3 2026 to $8.7M, even as nine-month R&D declined 4%.
• · Accounts receivable rose 38% and accrued revenue allowances rose 50% since December 31, 2025, which may warrant scrutiny of revenue collection and reserve trends.
• · Net cash used in operating activities was $15.7M for nine months 2026, a substantial improvement from $161.8M in nine months 2025.
• · Stockholders' deficit remains large at $(347.6)M, and total liabilities of $692.7M include a $387.5M revenue interest financing liability (current plus long-term).
• · Long-term debt was reduced through a $229.0M repayment, partly funded by $173.3M of new debt issuance and $122.0M of net equity offering proceeds in 2026.
• · Interest expense declined 4% YoY in Q3 2026 to $15.4M, while interest income rose 13% to $1.6M.
• · Shares outstanding increased about 14% to 81.2M since year-end 2025, reflecting the public offering and equity compensation issuance.

29-10-2026

Pediatrix Medical Group's Q3 2026 Form 10-Q shows net revenue of $501.4M, up 1.7% YoY from $492.9M, but net income fell 34.5% YoY to $47.0M from $71.7M, largely because the prior-year quarter included a $20.9M one-time gain on divested businesses. Diluted EPS declined to $0.59 from $0.84 (-29.8%). The company repurchased $147.2M of common stock in the nine months (vs. $22.6M a year earlier), reducing shares outstanding to 78.1M from 83.0M at year-start, while total debt was reclassified so that $179.9M is now current.

• · Practice salaries and benefits rose 2.8% YoY in Q3 2026 to $341.5M, outpacing net revenue growth of 1.7%.
• · Q3 2025 included a one-time $20.9M net gain on divested businesses, which is absent in Q3 2026 and drives most of the non-operating income decline.
• · Hospital contract administrative fees declined 1.1% YoY in Q3 2026 to $67.0M, while other revenue fell to $0.7M from $3.0M.
• · Current portion of debt rose to $179.9M from $26.8M at year-end 2025, a reclassification that increases near-term refinancing or repayment needs.
• · Accounts payable and accrued expenses fell to $342.9M from $419.5M, and accrued salaries and incentive compensation dropped to $194.1M from $248.1M.
• · Accumulated other comprehensive loss turned negative to $(1.7)M from $0.6M income at year-end, driven by unrealized losses on investments.
• · Goodwill increased by $7.5M from an acquisition in the nine months, while cash flows show only $7.0M in acquisition payments.
• · Deferred income tax assets declined to $45.2M from $73.9M at year-end 2025.

29-10-2026

NovoCure reported Q3 2026 net revenues of $193.4M, up 15.7% YoY from $167.2M, with gross profit rising to $148.9M and the operating loss narrowing to $6.2M from $36.0M. However, the company still posted a net loss of $10.4M for the quarter and a nine-month net loss of $97.2M, and nine-month operating cash flow of $17.3M was a sharp reversal from a $31.0M outflow a year earlier. Mixed signals also appear in G&A, which rose 25.9% for the nine months, and in the $25M current maturity of the senior secured credit facility.

• · Q3 2026 Research, development and clinical studies expense rose 7.5% YoY to $58.1M, while nine-month R&D grew only 2.6%
• · Q3 2026 financial income (expenses), net swung to an expense of $1.7M from $6.0M income in Q3 2025, and nine-month financial expense was $5.4M versus $18.1M income a year earlier
• · Q3 2026 income tax was a $2.6M expense versus $7.2M in Q3 2025; nine-month tax expense fell to $7.6M from $16.4M
• · Nine-month share-based compensation was $97.5M, a meaningful non-cash drag on reported results
• · Short-term investments of $366.7M plus cash of $96.7M provide liquidity against $196.3M of senior secured debt, with $25M due currently
• · Trade receivables rose to $108.3M from $89.4M at year-end 2025, a 21% increase that warrants watching against revenue growth

29-10-2026

ProPetro Holding Corp. reported Q3 2026 service revenue of $355.4M, up 20.9% YoY from $293.9M, and swung to operating income of $11.0M versus an operating loss of $6.1M a year earlier; Q3 net income was $13.0M ($0.09 diluted EPS) versus a net loss of $2.4M. However, nine-month revenue declined 4.8% YoY to $931.9M, nine-month operating income was essentially break-even at $(0.2)M, and nine-month net income was only $1.3M versus $0.1M in the prior year. The company raised $690.0M of convertible senior notes and $164.3M of equity during the period, while capital expenditures rose 86.7% YoY to $227.9M and cash rose to $728.9M from $91.3M at year-end 2025.

• · Q3 2026 G&A expenses rose 37.1% YoY to $30.8M, including stock-based compensation
• · Interest expense more than doubled in Q3 to $4.3M from $2.1M, and nine-month interest expense rose to $9.9M from $5.7M
• · Long-term debt rose to $808.7M from $105.6M at December 31, 2025, and total liabilities nearly tripled to $1.21B
• · Transaction price allocated to remaining performance obligations fell to $17.6M from $31.6M at December 31, 2025 and $27.7M a year earlier
• · Accounts receivable rose to $290.0M from $200.8M at year-end 2025, a 44.4% increase
• · Q3 2026 diluted EPS of $0.09 reflects dilution from convertible notes, with diluted shares of 154.7M versus 122.8M basic

29-10-2026

Alphabet reported Q3 2026 (three months ended September 30, 2026) revenues of $127,577 million, up 24.6% YoY from $102,346 million, and net income of $26,468 million, down 24.3% YoY from $34,979 million, as other income swung from a $12,759 million gain to an $8,221 million expense. Operating income grew 29.9% YoY to $40,576 million, while diluted EPS fell to $2.12 from $2.87, and expenses rose across R&D and cost of revenues even as general and administrative costs declined.

• · Other income swung from a $12,759 million gain in Q3 2025 to an $8,221 million expense in Q3 2026, the main driver of the net income decline despite stronger operating income.
• · Q3 2026 research and development expense rose 36.2% YoY to $20,640 million, while cost of revenues rose 24.4% and sales and marketing rose 22.2%.
• · Q3 2026 general and administrative expense fell 17.0% YoY to $6,138 million.
• · Nine-month 2026 net income includes a $127,478 million other income contribution versus $26,604 million in the prior-year period.
• · Long-term debt rose from $46,547 million to $125,102 million between December 31, 2025 and September 30, 2026.
• · Total cash, cash equivalents, and marketable securities rose to $265,098 million from $126,843 million at year-end 2025.
• · Q3 2026 other comprehensive loss of $(2,041) million compared with a gain of $73 million in Q3 2025, reducing comprehensive income to $24,427 million.

29-10-2026

Ford Motor Company's Form 10-Q for the quarter ended September 30, 2026 shows total revenues of $49,526 Million in Q3 2026, down from $50,534 Million in Q3 2025 (-2.0%), and $141,075 Million for the first nine months of 2026 versus $141,377 Million a year earlier (-0.2%). Net income attributable to Ford was $2,049 Million in Q3 2026, down from $2,447 Million (-16.3%), though first-nine-month net income rose to $3,270 Million from $2,882 Million (+13.5%), helped by a non-cash charge in the current period. Total assets grew to $292,484 Million from $289,160 Million at year-end 2025, while cash and marketable securities declined.

• · Q3 2026 vehicle, parts, and accessories revenue fell to $44,178 Million from $45,492 Million (-2.9%), while used vehicle revenue rose to $843 Million from $687 Million (+22.7%)
• · Company excluding Ford Credit net revenue fell 5.2% in Q3 on lower leasing income ($66 Million vs. $104 Million), while Ford Credit leasing income rose to $1,388 Million from $1,245 Million
• · Ford Credit financing income declined to $1,993 Million in Q3 2026 from $2,040 Million, and first-nine-month financing income fell to $5,990 Million from $6,094 Million
• · First-nine-month 2026 net income includes a $2,930 Million non-cash charge for the disposition of the BOSK investment, which weighed on operating cash flow reconciliation
• · Capital spending rose to $7,043 Million in the first nine months of 2026 from $6,031 Million, while dividend payments fell to $1,804 Million from $2,390 Million
• · Net changes in short-term debt were a $1,197 Million outflow in the first nine months of 2026 versus a $406 Million outflow a year earlier; Ford also repurchased $311 Million of common stock
• · Non-Ford Credit debt payable within one year fell to $4,154 Million from $5,550 Million, while long-term debt excluding Ford Credit rose to $19,535 Million from $16,369 Million
• · Q3 2026 net income was $2,049 Million versus $2,447 Million in Q3 2025, with Q3 2026 results including quarterly pension/OPEB income of $357 Million versus $19 Million a year earlier

29-10-2026

Cohu reported Q3 2026 (three months ended September 26, 2026) net sales of $172,956K, up 37.0% YoY from $126,249K, and net income of $12,129K versus a net loss of $(4,101)K a year earlier, with operating income of $12,801K compared to an operating loss of $(9,716)K. However, nine-month results remained near breakeven, with net loss of $(98)K (vs. $(51,785)K) and operating income of only $1,939K, and gross margin on a cost-of-sales basis compressed as cost of sales rose faster than revenue on a nine-month basis (cost of sales +30.6% vs. net sales +35.2% in the same comparison, while inventories and receivables grew substantially).

• · Nine-month 2026 cash used in investing included $206,678K in sales/maturities of short-term investments offset by $183,960K in purchases, and capex fell to $6,961K from $17,583K.
• · Long-term debt of $285,212K and short-term borrowings of $15,636K at September 26, 2026, with nine-month interest expense rising to $5,054K from $434K.
• · Nine-month restructuring charges declined to $1,839K from $8,347K, and amortization of purchased intangibles fell to $21,754K from $30,182K.
• · Accumulated other comprehensive loss widened to $(40,691)K from $(32,470)K at year-end 2025, driven by a $(7,128)K cumulative translation adjustment.
• · Q3 2026 diluted EPS of $0.22 compares with basic EPS of $0.26, reflecting dilution to 54,366K diluted shares.
• · Nine-month 2026 foreign transaction losses of $(1,150)K widened from $(551)K a year earlier.

29-10-2026

Pilgrim's Pride reported Q3 2026 net sales of $4,653.2 Million, down 2.2% from $4,759.3 Million in Q3 2025, and net income attributable to the company of $117.6 Million versus $342.8 Million a year earlier (-65.7%). Diluted EPS fell to $0.49 from $1.44. Nine-month net sales of $13,812.1 Million declined 1.2% YoY, and nine-month diluted EPS of $0.97 compares with $4.17 in the prior year, though sequentially Q3 net income rose from the Q2 base reflected in the equity roll-forward. Gross profit contracted sharply, with the Q3 gross margin falling to about 7.2% from 13.9%.

• · Nine-month 2025 included a $1,994.3 Million special cash dividend (Q3 2025: $498.9 Million), which drove retained earnings down sharply in 2025 and is absent in 2026
• · Q3 2026 restructuring expense was nil versus $1.8 Million in Q3 2025, while nine-month 2026 restructuring was $11.5 Million versus $21.9 Million
• · Nine-month 2026 SG&A rose to $587.4 Million from $498.2 Million (+17.9%), even as Q3 SG&A fell 13.8% to $142.2 Million
• · Interest income fell sharply to $1.6 Million in Q3 2026 from $9.2 Million, and nine-month interest income declined to $12.2 Million from $45.1 Million
• · Accumulated other comprehensive loss widened to $(100.8) Million from $(47.0) Million at year-end 2025, driven largely by foreign currency translation losses
• · Long-term debt rose to $3,404.7 Million from $3,093.1 Million at December 28, 2025, while cash increased to $935.8 Million from $640.2 Million
• · Income tax expense fell to $44.0 Million in Q3 2026 from $118.3 Million, with the effective tax rate around 27.4%

29-10-2026

Ford Motor Credit Company LLC's 10-Q for the period ended September 30, 2026 shows total assets of $161,562 Million, down from $162,453 Million at December 31, 2025, and total shareholder's interest of $14,538 Million, down from $14,804 Million. Nine-month net income rose to $2,438 Million from $1,533 Million a year earlier (+59%), but cash distributions to parent more than doubled to $2,625 Million from $1,050 Million, and total debt declined to $139,393 Million from $141,417 Million. Net cash from operating activities increased to $3,395 Million from $2,899 Million, while net cash used in investing activities widened to $2,200 Million from $820 Million, and cash, cash equivalents, and restricted cash fell to $8,355 Million from $9,377 Million at year-end 2025.

• · Net investment in operating leases rose to $28037 Million from $26502 Million, while consumer retail financing, gross fell about 3% to $86831 Million from $89858 Million.
• · Net cash used in investing activities widened to $2200 Million from $820 Million, driven by lower net collections of wholesale receivables ($920 Million outflow versus $2635 Million inflow a year earlier).
• · Cash distributions to parent of $2625 Million in the first nine months exceeded net income of $2438 Million, reducing shareholder's interest and retained earnings to $10146 Million from $10333 Million at year-end 2025.
• · Accumulated other comprehensive loss widened to $(774) Million from $(695) Million at year-end 2025.
• · Allowance for credit losses increased to $984 Million from $911 Million, while the provision for credit losses rose to $495 Million from $389 Million in the first nine months.
• · Derivative liabilities rose to $1870 Million from $947 Million, while derivative assets declined to $1264 Million from $1528 Million.

29-10-2026

Hippo Holdings reported Q3 2026 net income of $8.8M versus $98.1M in Q3 2025, a sharp decline driven by the absence of the prior-year $95.0M gain on sale of business; total revenue grew 29.3% YoY to $156.0M. Nine-month net income attributable to Hippo was $26.0M versus $51.7M a year earlier, while total revenue rose 21.3% to $422.2M and operating cash flow improved to $124.2M from $6.0M.

• · Diluted EPS fell to $0.33 in Q3 2026 from $3.77 in Q3 2025; nine-month diluted EPS was $0.98 versus $1.97
• · Accumulated other comprehensive loss widened to $(14.5)M from $1.8M at year-end 2025, driven by unrealized losses on fixed maturities
• · Ceding commissions receivable rose to $254.4M from $98.7M and reinsurance premiums payable rose to $590.4M from $304.4M since December 31, 2025
• · Losses and LAE in Q3 2026 rose 53.1% YoY to $72.7M, outpacing premium growth and compressing underwriting margins
• · Cash and restricted cash of $326.8M and a $124.2M nine-month operating cash inflow, versus $6.0M a year earlier

29-10-2026

Century Communities reported Q3 2026 total revenues of $864.5M, down 11.8% YoY from $980.3M, and net income of $12.6M, down 66.3% from $37.4M, with diluted EPS of $0.44 versus $1.25 a year earlier. For the nine months, revenues fell 10.5% to $2,581.4M and net income declined 34.5% to $73.2M, while the company repurchased $71.2M of stock and paid $27.5M in dividends; however, operating cash flow was negative $267.5M as inventories rose $403.4M, and the revolving credit line balance climbed to $456.0M from $51.5M at year-end 2025.

• · Q3 2026 Southeast segment pre-tax income rose to $9.0M from $13.2M while West swung to a $13.5M pre-tax loss, versus $21.2M profit a year earlier
• · Inventories grew to $3,744.0M from $3,361.2M at year-end 2025 and inventory impairments reached $19.6M for nine months versus $11.0M a year earlier
• · Revolving credit borrowings rose to $456.0M from $51.5M at December 31, 2025, while notes payable increased to $1,165.3M
• · Nine-month basic and diluted EPS of $2.55 and $2.54 compare with $3.69 and $3.65 a year earlier
• · Cash and cash equivalents fell to $86.1M from $109.4M at year-end 2025 and restricted cash totaled $23.7M

29-10-2026

Titan International reported Q3 2026 net sales of $335,177K, down 6.2% from $357,258K in Q3 2025, and a net loss attributable to Titan of $(42,744)K versus $(2,262)K a year earlier, driven largely by a $33,650K loss from discontinued operations. Nine-month net sales rose modestly to $1,096,620K from $1,086,771K (+0.9%), but operating results weakened, with a loss from operations of $(12,830)K versus income of $13,289K, reflecting $27,418K in restructuring and other charges. Basic and diluted loss per share attributable to Titan was $(0.66) for the quarter and $(0.95) for nine months.

• · Q3 2026 gross profit fell to $49,415K from $56,074K (-11.9%), with gross margin compressing to about 14.7% from 15.7%
• · Q3 2026 SG&A declined to $42,959K from $45,793K (-6.2%), while R&D rose to $3,299K from $3,116K (+5.9%)
• · Nine-month restructuring charges of $27,418K were recorded versus none in 2025; no restructuring charges were recorded in Q3 2025
• · Nine-month interest expense increased to $29,709K from $28,935K, and foreign exchange loss widened to $(1,103)K from $(4,750)K, a smaller loss year-over-year
• · Cash and cash equivalents declined to $172,787K from $202,879K at year-end 2025; total debt (short-term plus long-term) was roughly $566,141K versus $578,892K at year-end 2025
• · Total Titan equity fell to $456,045K from $514,380K, with retained earnings dropping to $39,375K from $100,569K
• · Comprehensive loss attributable to Titan was $(46,911)K in Q3 2026 versus $(3,244)K in Q3 2025, and nine-month comprehensive loss was $(62,650)K versus comprehensive income of $69,862K in 2025 (2025 benefited from a large currency translation gain)
• · Nine-month operating cash flow from continuing operations improved to $19,278K from $1,827K, while total operating cash flow was $9,758K versus $17,243K
• · Capital expenditures were $25,232K for nine months 2026, down from $30,344K in 2025

29-10-2026

CP reported Q3 2026 total revenues of C$4,219 million, up 15.3% YoY from C$3,661 million, with net income of C$916 million, essentially flat versus C$917 million a year earlier. Diluted EPS was C$1.04 versus C$1.01, supported by a 3.6% lower diluted share count following heavy buybacks, while operating expenses rose 17.5% (fuel up 61% YoY) and operating income grew 11.3%. For the nine months, revenue rose 8.3% to C$12,084 million, but net income fell 9.0% to C$2,785 million because the prior-year period included a C$333 million gain on sale of an equity investment, and diluted EPS of C$3.14 compared with C$3.32.

• · Coal revenue fell 10.3% in nine months (C$689M vs C$768M) and Q3 coal was flat at C$254M vs C$255M
• · Q3 Non-freight revenue rose to C$80M from C$72M, while Q3 equipment rents declined to C$101M from C$109M
• · Q3 Net interest expense rose 7.7% to C$239M from C$222M, and long-term debt increased to C$22,233M from C$19,948M at year-end 2025
• · Q3 Operating cash flow grew 21.6% to C$1,550M, and cash position rose to C$399M from C$184M at year-end 2025
• · Capital expenditures (additions to properties) declined to C$613M in Q3 from C$860M, and nine-month additions fell to C$2,035M from C$2,314M
• · Shareholders' equity declined slightly to C$45,779M from C$45,877M at year-end 2025, as buybacks and dividends offset OCI gains
• · Q3 dividends declared per share rose 17.5% to C$0.268 from C$0.228

29-10-2026

Bausch Health reported Q3 2026 revenue of $2,941 Million, up 9.7% YoY from $2,681 Million, and net income attributable to the company of $436 Million versus $179 Million a year earlier. However, nine-month results were weak: the company posted a net loss attributable to Bausch Health of $(729) Million versus net income of $269 Million in the prior-year period, driven by a $1,426 Million goodwill impairment, and nine-month operating income fell 42.3% to $773 Million from $1,339 Million. Total shareholders' deficit widened to $(1,328) Million from $(554) Million at year-end 2025.

• · Nine-month 2026 goodwill impairment of $1,426 Million is the primary driver of the net loss swing; goodwill fell to $9,767 Million from $11,271 Million at year-end 2025.
• · Accumulated deficit widened to $(10,396) Million from $(9,667) Million at December 31, 2025.
• · Non-current long-term debt declined to $19,771 Million from $20,592 Million, while current portion of long-term debt rose to $866 Million from $225 Million.
• · Net cash provided by operating activities nearly doubled to $1,714 Million for nine months from $905 Million, with cash and cash equivalents rising to $2,485 Million from $1,309 Million.
• · Amortization of intangible assets declined to $693 Million for nine months from $765 Million, and Q3 2026 R&D spending fell 15.1% YoY.
• · Nine-month 2026 provision for income taxes rose to $316 Million from $88 Million despite a pre-tax loss of $(409) Million.
• · Foreign currency translation turned to a $(96) Million nine-month loss from a $356 Million gain a year earlier.

29-10-2026

Portland General Electric reported Q3 2026 total revenues of $971 million, up 2.0% YoY from $952 million, and net income of $119 million, up 15.5% from $103 million. However, nine-month results were weaker: total revenues fell 0.8% to $2,664 million, net income declined 12.5% to $232 million, and diluted EPS dropped from $2.41 to $1.98. Wholesale revenues fell sharply in the nine-month period (down 24.4%), while industrial sales grew strongly.

• · Nine-month diluted EPS fell 17.8% to $1.98 from $2.41, a steeper decline than the 12.5% drop in net income due to share count growth from equity issuance (diluted shares up roughly 6.5%)
• · Nine-month income from operations declined 9.8% to $415M from $460M, and Q3 income from operations rose 7.5% to $187M
• · Residential retail revenues fell 3.5% in Q3 to $362M from $375M and 2.2% over nine months
• · Cash and cash equivalents declined to $69M from $76M at year-end 2025; operating cash flow fell 16.4% to $811M from $970M
• · Long-term debt rose to $5,010M from $4,662M at December 31, 2025, and dividends paid rose 10.2% to $184M

29-10-2026

Viking Therapeutics reported a Q3 2026 net loss of $183.2M (Q3 2025: $90.8M) and a nine-month net loss of $469.5M (9M 2025: $202.0M), driven by R&D expense rising to $166.8M in the quarter from $90.0M a year earlier. The company has no revenue in either period, and cash, equivalents and short-term investments totaled approximately $960M at September 30, 2026, following a 10.5M-share equity sale and the issuance of $250.7M of convertible senior notes.

• · Company reported zero revenue in both Q3 2026 and Q3 2025, and in both nine-month periods, so all losses are unfunded by product sales
• · Interest income fell roughly half year over year (down 48.4% in Q3 and 46.1% for nine months), reflecting lower average invested balances and/or yields, even as cash balances rose sharply
• · Stockholders' equity declined 7.9% from December 31, 2025 despite $379.6M of equity raised in the nine months, because the $469.5M net loss outpaced new capital
• · Accumulated deficit reached $1.32B, up from $847.5M at year-end 2025
• · Basic and diluted loss per share widened to $(1.55) in Q3 2026 from $(0.81), and to $(4.03) for nine months from $(1.80), partly reflecting a larger weighted share count (118.1M in Q3 vs. 112.3M)
• · Total liabilities rose to $388.6M from $76.7M, driven by the $250.7M convertible senior notes and higher accounts payable ($82.1M) and accrued liabilities ($51.7M)

29-10-2026

Sabine Pass Liquefaction, LLC reported Q3 2026 total revenues of $2,523M, up 7.1% YoY from $2,355M, and net income of $688M, up 30.3% from $528M. Nine-month net income rose to $1,952M from $1,742M (+12.1%), while nine-month total revenues increased 11.8% to $8,605M from $7,699M. Performance was mixed: cost of sales rose sharply for the nine months to $4,894M from $4,177M (+17.2%), and operating and maintenance expense at the non-affiliate level increased to $601M from $592M in the nine-month period and $206M from $161M in the quarter.

• · Nine-month derivative losses of $278M contrasted with a $109M gain in the prior-year period.
• · Nine-month operating and maintenance expense from related parties was $0 versus $28M a year earlier.
• · Current derivative liabilities fell to $84M from $164M and non-current derivative liabilities fell to $41M from $900M.
• · A new deferred NPNS liability of $1,158M (current $103M plus non-current $1,055M) was recorded, with estimated cost-of-sales reductions of $1,189M through 2030 and beyond.
• · Contributions from the member of $1,425M in the first nine months of 2026 exceeded the $830M contributed in the same period of 2025, while distributions rose to $1,890M from $1,245M.
• · Restricted cash rose to $35M from $19M at year-end 2025.

29-10-2026

Cheniere Corpus Christi Holdings, LLC reported Q3 2026 total revenues of $2,723 Million, up from $1,478 Million in Q3 2025 (+84%), and net income of $555 Million versus $1,009 Million a year earlier (-45%). For the nine months ended September 30, 2026, the company posted a net loss of $553 Million compared with net income of $2,409 Million in the prior-year period, driven largely by a $2,196 Million loss on derivative instruments and a $467 Million operating loss. Mixed performance: revenue and cash from operations grew, while profitability declined sharply.

• · Q3 2026 cost of sales (third party) rose to $1,506 Million from $106 Million, a major driver of the margin squeeze
• · Nine-month 2026 loss on modification or extinguishment of debt of $28 Million
• · Non-cash member's equity contributions of $552 Million (Q1) and $240 Million (Q2) in 2026
• · Deferred NPNS assets of $1,509 Million and deferred NPNS liabilities of $644 Million recognized at September 30, 2026, reflecting a reclassification of $869 Million net
• · Derivative assets fell to $780 Million from $3,913 Million at December 31, 2025, while current debt rose to $1,237 Million from zero

29-10-2026

Cheniere Energy reported Q3 2026 total revenues of $6,173 Million, up 39% YoY from $4,441 Million, and Q3 net income attributable to Cheniere of $1,170 Million, up 12% from $1,049 Million. However, nine-month income from operations fell 49% to $2,717 Million from $5,308 Million, and nine-month net income attributable to Cheniere declined 76% to $736 Million from $3,028 Million, reflecting a large non-cash derivative loss of $3,015 Million in the period. Cost of sales rose sharply, and total stockholders' equity declined to $11,970 Million from $12,942 Million at year-end 2025 after $1,819 Million of nine-month share repurchases.

• · Nine-month operating cash flow rose 47% to $5,124 Million despite the sharp drop in reported net income, largely because the $3,015 Million derivative loss is non-cash
• · Cost of sales more than doubled YoY in Q3 (+83%), compressing the margin between LNG revenues and feedstock costs relative to 2025
• · Long-term debt increased modestly to $22,582 Million, and current debt rose to $1,349 Million from $306 Million at year-end 2025
• · Net NCI income rose to $980 Million for nine months from $833 Million, meaning a larger share of earnings accrues to non-controlling interests
• · Treasury stock grew to $10,688 Million (74.5M shares) from $8,852 Million, reflecting continued buybacks that reduced shares outstanding by roughly 7M since year-end 2025
• · Deferred NPNS assets of $2,178 Million and deferred NPNS liabilities of $1,699 Million (plus current portion of $166 Million) appeared on the balance sheet, with a $349 Million net reclassification noted

29-10-2026

Cheniere Energy Partners, L.P. (CQP) reported Q3 2026 total revenues of $2,574 Million, up 7.1% from $2,404 Million in Q3 2025, and net income of $639 Million, up 26.3% from $506 Million, with net income per common unit rising to $1.01 from $0.80. Nine-month results were also stronger, with revenues of $8,757 Million (up 11.6% from $7,848 Million) and net income of $1,986 Million (up 16.8% from $1,700 Million). However, cost of sales rose sharply on a nine-month basis (up 13.9% to $4,757 Million) and operating and maintenance expense in Q3 rose 23.6% to $236 Million, while the company's partners' equity recovered to $879 Million from $414 Million at year-end 2025.

• · Nine-month cash flow from operations rose 35.6% to $2,550 Million, while capital expenditures nearly tripled to $526 Million, up from $176 Million.
• · Operating and maintenance expense in Q3 2026 rose 23.6% YoY to $236 Million, a notable cost pressure despite revenue growth.
• · Q3 2026 cost of sales was essentially flat YoY at $1,276 Million, while nine-month cost of sales rose 13.9% to $4,757 Million.
• · Cash and cash equivalents increased to $569 Million from $182 Million at year-end 2025, and current debt fell to $112 Million from $306 Million.
• · Long-term debt rose modestly to $14,283 Million from $14,161 Million at year-end 2025.
• · The company recognized $669 Million in deferred NPNS assets and $1,158 Million in combined NPNS liabilities (current and non-current) that are being amortized as a net reduction to cost of sales, with $520 Million total estimated amortization through 2030 and beyond.
• · Derivative liabilities declined sharply to $41 Million (non-current) from $900 Million at year-end 2025, while derivative assets fell from $541 Million to $1 Million.

29-10-2026

NextDecade Corp reported Q3 2026 net income attributable to common stockholders of $155.4 million ($0.58 basic EPS), a sharp swing from a $109.5 million loss in Q3 2025, driven primarily by an $851.2 million derivative gain, which more than offset $69.3 million in interest expense and a $136.5 million loss on debt extinguishment. The company generated no revenue and remains in its construction phase, with Rio Grande LNG Facility assets under construction growing to $14.4 billion, while total debt rose to $12.0 billion and nine-month operating cash flow was negative at $16.6 million. Results are heavily dependent on non-cash derivative fair value movements, and nine-month net loss attributable to common stockholders remains $46.5 million.

• · Derivative gain of $851.2M in Q3 2026 is non-cash fair value movement and is the primary driver of the quarterly profit; the same line showed a $74.1M loss in Q3 2025
• · Interest expense rose 72% YoY in Q3 and more than doubled (+141%) over nine months, with $89.8M of interest elected to be paid-in-kind in the nine-month period
• · Loss on debt extinguishment of $136.5M in Q3 2026 ($169.0M for nine months) compared with $0 in Q3 2025
• · Operating cash flow remained negative at -$16.6M for nine months, versus -$148.7M a year earlier, an improvement but still negative
• · Cash and cash equivalents fell 9.7% since year-end to $129.9M, and restricted cash declined 18.0% to $462.2M
• · Non-controlling interests now represent $3.64B of total equity (97% of total equity), with stockholders' equity of only $111.8M, reflecting the consolidated VIE structure
• · Finance lease right-of-use assets of $996.3M were newly recognized, with finance lease payments of $17.7M in the nine-month period
• · Weighted average discount rates are 7.0% for operating leases and 6.8% for finance leases; operating lease term is 41.0 years
• · Accumulated deficit widened to $806.4M from $760.0M at year-end 2025 despite Q3 profit
• · Revenues remained at zero throughout all periods, with the company still pre-revenue

29-10-2026

Escalade Inc reported Q3 2026 net sales of $65.6M, down 3.2% YoY from $67.8M, while net income rose 21.2% to $6.7M, driven by a $1.6M tariff recovery and lower cost of products sold. For the nine months, net sales grew 0.8% to $179.1M and net income more than doubled to $20.5M, including an $11.5M tariff recovery. Gross sales from mass merchants, specialty dealers, and e-commerce channels were mixed, with mass merchants and the quarter's total gross sales declining year over year.

• · Q3 2026 gross sales fell 3.8% YoY to $72.4M, while the nine-month gross sales were essentially flat at $197.5M
• · Mass merchant gross sales declined 7.0% in Q3 and 7.6% over nine months, the weakest channel
• · Customer allowances fell 12.4% in Q3 and gross-to-net adjustments fell 9.5%, partly offsetting gross sales declines
• · Nine-month net income benefited from an $11.5M tariff recovery and $0.7M interest income, versus no comparable items in 2025
• · Long-term debt was fully reclassified to current ($13.1M) at September 30, 2026, with no long-term debt remaining on the balance sheet
• · Trade payables rose to $21.9M from $9.2M at December 31, 2025, a seasonal increase that accompanied higher cash balances
• · Dividends declared rose to $0.1525 per share in Q3 2026 from $0.1500 a year earlier

29-10-2026

CSW Industrials reported Q2 FY2027 (three months ended September 30, 2026) revenue of $361.4M, up 30.5% YoY from $277.0M, and net income attributable to CSW of $47.3M, up 16.4% from $40.7M; diluted EPS was $2.90 versus $2.41. Six-month revenue rose 31.7% to $712.1M. However, interest expense rose sharply to $12.5M from $1.3M in the quarter, other income turned to a slight loss for the six months ($(0.2)M vs. $0.5M), and the company remains highly leveraged with long-term debt of $735.1M, though down from $839.8M at March 31, 2026.

• · Interest expense rose to $12.5M in the quarter from $1.3M, reflecting higher debt costs tied to recent acquisition financing and a larger balance sheet burden.
• · Other income (loss), net was $0.04M for the quarter but a $(0.2)M loss for the six months, reversing a $0.5M gain in the prior-year period.
• · Gross margin was 42.0% in the quarter versus 43.0% a year ago, a modest compression despite higher revenue.
• · Operating cash flow was $171.0M for six months, up 39.7% from $122.5M, aided by a $43.7M increase in payables and other current liabilities.
• · Purchase accounting for a prior acquisition was adjusted, reducing total purchase price by $9.4M to $658.1M and goodwill by $5.5M to $259.4M, with customer lists increased by $5.0M.
• · Treasury share purchases of $42.2M for six months rose 61.8% from $26.1M, while cash ended the period at $37.2M.

29-10-2026

Blackstone Mortgage Trust reported a Q3 2026 net loss attributable to common stockholders of $327.0 Million (EPS of $(1.95)), compared with net income of $63.4 Million ($0.37 per share) in Q3 2025. The swing was driven by a $264.8 Million increase in the CECL reserve, a $63.9 Million valuation adjustment on loans held-for-sale, and a $36.4 Million impairment of owned real estate. Total net revenue rose 6.9% YoY to $141.9 Million, supported by owned real estate revenue, while net interest income from loans fell 34.8% YoY.

• · Net loss attributable to common stockholders for nine months 2026 was $414.5 Million versus net income of $70.0 Million in the prior-year period.
• · Secured debt declined to $7.19B from $10.12B at December 31, 2025, while senior secured notes rose to $1.19B from $0.78B, reflecting refinancing toward unsecured-style and securitized structures.
• · Dividends declared were $0.47 per share in each of Q1, Q2 and Q3 2026, unchanged sequentially despite the Q3 loss.
• · Accumulated deficit widened to $(2.60)B from $(1.95)B at year-end 2025.
• · Net cash from investing activities of $1.93B in 9M 2026 was driven by loan principal collections of $4.04B exceeding fundings of $1.81B, consistent with a shrinking loan book.
• · Repurchases of Class A common stock totaled $39.9 Million in 9M 2026, while 2.3 million shares were retired from year-end 2025 to September 30, 2026.
• · Owned real estate expenses rose to $81.2 Million in Q3 2026 from $43.1 Million, nearly matching the $77.5 Million of owned real estate revenue, compressing the margin on REO assets.
• · Weighted-average all-in yield on held-for-investment loans improved to 3.43% from 3.39% at year-end, while cash coupon eased to 3.08% from 3.19%.

29-10-2026

Butterfly Network reported Q3 2026 total revenue of $32.6M, up 51.7% YoY from $21.5M, driven by a sharp rise in software and other services revenue (+144.7% to $17.0M), while product revenue grew a modest 7.4% to $15.6M. Net loss narrowed to $12.8M from $34.0M a year earlier, but cash and cash equivalents declined to $122.3M from $150.5M at year-end 2025 as operating cash burn continued, with nine-month operating cash outflow of $32.4M versus $21.7M in the prior-year period.

• · Gross profit swung to $23.8M from a $3.8M gross loss in Q3 2025, driven largely by a sharp drop in product cost of revenue ($6.8M vs. $23.6M), which was inflated by prior-year write-downs.
• · Nine-month 2025 results included $7.9M of inventory write-downs and $9.6M of vendor advance write-downs; neither recurred in 2026, flattering the year-over-year comparison.
• · Product revenue was essentially flat on a nine-month basis (+1.5%), with all top-line growth coming from software and other services.
• · Accrued expenses and other current liabilities rose 44% to $46.4M from $32.2M at year-end, a meaningful contributor to the cash flow profile.
• · Deferred revenue (current) fell 40.8% to $15.9M, and nine-month deferred revenue drew down $9.2M in operating cash flow.
• · Operating expenses rose 19.1% YoY in Q3 to $37.4M, with general and administrative expense up 24.5% and R&D up 16.9%.
• · No share offering proceeds were received in 2026 versus $81.0M raised in 2025; the company funded its operating burn from its existing cash balance.
• · Class B shares declined by 5,000,000 through conversion to Class A during Q3 2026.

29-10-2026

Bridgewater Bancshares reported Q3 2026 net income of $15.0M (diluted EPS $0.49), up from $11.6M ($0.38) in Q3 2025, driven by net interest income growth of 19.3% YoY to $40.7M. However, nine-month net income rose 41.8% to $46.4M only partly due to a one-time gain on securities sales, and quarterly comprehensive income turned negative at $(7.2)M due to a $(22.3)M swing in unrealized losses on available-for-sale securities. Total assets grew 3.9% since year-end to $5.62B, while noninterest-bearing deposits declined 3.2% YTD.

• · Nine-month 2026 net gains on AFS securities of $7.25M (Q3 alone was zero) boosted earnings; gross losses on sales of $9.34M were also realized in the period
• · Q3 2026 provision for credit losses rose to $2.75M from $1.10M a year earlier, roughly 2.5x higher
• · Q3 2026 salaries and employee benefits rose 17.4% YoY to $14.35M, the largest expense increase, and nine-month expenses grew 14.7% to $65.4M
• · Interest expense on deposits fell 10.6% YoY in Q3, the main driver of the margin improvement alongside higher loan interest income (+11.2% YoY)
• · FHLB prepayment penalty of $0.98M incurred in the nine months 2026 with no comparable prior-year charge
• · Bank-owned life insurance balance rose 56.3% YTD to $72.8M following $26.6M in purchases
• · Cash flow from operations improved to $71.9M for nine months from $20.8M, supported by a $31.4M increase in accrued liabilities and other liabilities

29-10-2026

PBF Energy reported Q3 2026 revenues of $12,132.8M, up 58.6% from $7,651.1M in Q3 2025, and net income attributable to PBF Energy stockholders of $1,529.3M versus $170.1M a year earlier. Results were helped by a $62.4M equity income from investees and a $0.7M loss on asset sales, while G&A rose 72.2% to $127.4M and the company recorded a $28.0M loss on debt extinguishment; the Q3 2025 comparison also included a $250.0M gain on insurance recoveries that did not recur. Nine-month net income attributable to PBF Energy was $2,634.0M versus a loss of $236.9M in the prior-year period.

• · Q3 2026 cost of products and other rose 33.2% to $9,107.6M from $6,839.3M, the main driver of higher cost of sales
• · Accrued expenses increased to $4,048.1M from $2,662.9M, contributing $1,408.3M to nine-month operating cash flow
• · Nine-month operating cash flow of $3,142.8M compared with cash used of $444.6M in the prior-year period, with working capital build of roughly $904M in receivables and $339M in inventories absorbing cash
• · Non-cash lower of cost or market inventory adjustment of $313.0M was recorded in the nine months 2026
• · Deferred tax liabilities rose to $1,157.8M from $763.6M, and Q3 2026 income tax expense was $503.8M versus $64.3M
• · Q3 2025 operating results were boosted by a $250.0M gain on insurance recoveries and a $94.0M gain on asset sales, neither of which recurred in 2026 to the same extent
• · Quarterly dividend held at $0.275 per common share; nine-month dividends totaled $0.825 per share
• · Interest expense fell to $27.2M from $50.3M in Q3, reflecting the debt refinancing activity
• · Nine-month 2026 insurance premium financing: $158.7M proceeds vs $122.2M repayments

29-10-2026

Tradeweb Markets reported Q3 2026 total revenue of $584.5M, up 14.9% YoY from $508.6M, and net income attributable to Tradeweb of $197.5M, up 6.4% from $185.6M. However, diluted EPS of $0.94 was up only modestly from $0.86, and general and administrative expenses for the nine months fell 31.1% YoY to $45.9M while professional fees for Q3 rose 72.1% to $19.8M. Share repurchases accelerated sharply, totaling $447.3M for the nine months versus $0.8M a year earlier, reducing Class A shares outstanding.

• · Q3 2026 operating income rose 20.5% YoY to $253.4M, outpacing revenue growth, though other income fell 52.5% to $18.7M and cut the pre-tax benefit.
• · Subscription fees were nearly flat YoY in Q3 (+1.0%), and other revenue declined 18.8% for the quarter.
• · Professional fees rose 72.1% YoY in Q3 to $19.8M, a notable cost increase.
• · Nine-month share repurchases of $447.3M compare with $0.8M in the prior-year period, and Class A shares outstanding fell from 115.5M at December 31, 2025 to 112.1M at September 30, 2026.
• · Nine-month net cash from operating activities rose 4.1% to $845.3M, while financing outflows increased to $652.4M from $162.2M.

29-10-2026

Altisource Portfolio Solutions S.A. reported Q3 2026 revenue of $51.9M, up 24% YoY from $41.9M, and nine-month revenue of $150.2M, up 17% from $128.6M. Net loss attributable to Altisource widened to $1.4M in Q3 2026 from $2.4M in Q3 2025 on a narrower loss, but the nine-month result swung to a $2.6M loss from $8.8M of net income a year earlier, driven by a $15.1M tax benefit in 2025 that did not recur. Total deficit remained negative at $(109.9)M, and cash fell to $25.1M from $26.6M at year-end 2025.

• · Q3 2026 gross margin compressed to roughly 23.3% from 27.1% in Q3 2025 as cost of revenue grew 30% against 24% revenue growth
• · Nine-month 2025 net income was driven by a $15.1M income tax benefit; 2026 nine-month results carry a $1.8M tax provision, so the swing is largely tax-driven
• · Servicer and Real Estate segment share of revenue fell sharply to 33% in Q3 2026 from 53% a year earlier, and to 41% from 54% for nine months, indicating a shift in revenue mix
• · Accounts receivable rose 48% to $26.7M since year-end 2025 while cash declined, and nine-month operating cash flow of $1.3M reflects a $9.0M cash outflow from receivables growth
• · Q3 2026 SG&A rose 4.9% YoY and nine-month SG&A rose 12.2%, outpacing the 17% revenue growth only modestly for the quarter but reducing nine-month operating income by 48%
• · Interest expense declined to $6.4M for nine months from $9.9M, aided by debt repayments, a $1.0M gain on early extinguishment of debt, and $3.6M of debt premium amortization
• · Total deficit widened slightly to $(109.9)M, and Altisource stockholders' deficit remained negative throughout the period
• · Weighted average basic shares rose to 11.4M in Q3 2026 from 11.0M a year earlier, with equity issued in 2025 (including $42.2M in Q1 2025) driving the increase

29-10-2026

Insmed reported Q3 2026 product revenues, net of $524.4 Million, up roughly 268% from $142.3 Million in Q3 2025, and net loss narrowed to $100.3 Million from $370.0 Million, driven largely by a favorable swing in contingent consideration. However, operating expenses rose sharply: R&D increased 45% to $270.0 Million and SG&A increased 36% to $253.0 Million, while cash and marketable securities declined to $1,146.6 Million from $1,429.9 Million at year-end 2025 and operating cash outflow for the nine months was $348.0 Million versus $687.4 Million a year earlier.

• · Accounts receivable rose to $259.3 Million from $140.9 Million at year-end 2025 (up about 84%), and inventory rose to $163.9 Million from $132.1 Million, signaling working capital build alongside revenue growth
• · Accounts payable and accrued liabilities increased to $574.5 Million from $456.1 Million at year-end 2025
• · Nine-month net loss narrowed to $277.1 Million from $948.3 Million, but the nine-month 2026 result includes a $139.2 Million favorable fair value change in contingent consideration; contingent consideration liability fell to $178.1 Million from $314.3 Million
• · Shares outstanding increased to 219.3 Million from 214.3 Million at year-end 2025, including 0.36 Million shares issued for a business acquisition milestone ($54.9 Million)
• · Diluted and basic loss per share was $(0.46) in Q3 2026 versus $(1.75) in Q3 2025, with no dilutive securities included due to net losses
• · Operating lease and finance lease liabilities together totaled roughly $39.8 Million at Sept 30, 2026
• · Cash paid for interest was $39.8 Million for nine months 2026 versus $41.8 Million in 2025

29-10-2026

Bicycle Therapeutics reported Q3 2026 collaboration revenue of $34.1M, up from $11.7M in Q3 2025, driven by Bayer collaboration revenue of $34.1M versus $1.0M a year earlier. Net loss narrowed to $10.5M ($0.15 per share) from $59.1M ($0.85 per share), as R&D expense fell 43% YoY to $33.4M and G&A fell 25% to $14.1M. However, cash and cash equivalents declined to $469.9M from $628.1M at December 31, 2025, operating cash burn for the nine months was $155.8M, and total deferred revenue dropped sharply as the Bayer deferred balance was fully recognized.

• · Bayer collaboration deferred revenue of $34.6M at January 1, 2026 was fully recognized as revenue by September 30, 2026, leaving no remaining balance from this agreement
• · Novartis, Ionis, and Genentech contributed no collaboration revenue in the nine months ended September 30, 2026, versus $5.1M, $2.0M, and $14.7M respectively in the prior-year period
• · Net loss for the nine months ended September 30, 2026 was $121.6M, a 38.8% improvement from $198.8M a year earlier
• · Accumulated deficit reached $1,021.4M, and total shareholders' equity declined to $505.3M from $610.0M
• · R&D incentives receivable rose to $52.4M from $35.6M at year-end 2025

29-10-2026

Garrett Motion reported Q3 2026 net sales of $930 million, up 3% from $902 million in Q3 2025, and net income of $97 million versus $77 million a year earlier, with diluted EPS of $0.51 against $0.38. Nine-month net sales rose 7% to $2,891 million and net income increased 30% to $293 million. However, Q3 gross margin was essentially flat at about 22.2% versus 20.6% (improved), while nine-month cost of goods sold grew faster than sales, and the balance sheet still shows a total deficit of $618 million, though improved from $802 million at year-end 2025.

• · Q3 2026 gross margin was about 22.2% versus 20.6% in Q3 2025, while nine-month cost of goods sold rose 6.1% in line with sales growth of 7.4%
• · Accounts receivable rose to $801M from $703M and inventories to $386M from $339M, with operating cash flow pressured by a $103M receivables build over nine months
• · Accounts payable increased to $1,107M from $1,061M, supporting working capital
• · Shares outstanding declined to 185.4M from 190.6M at year-end 2025 as the company repurchased $172M of stock in nine months
• · Foreign exchange translation and net investment hedge gains contributed to nine-month other comprehensive income of $111M, versus a $219M loss in the prior-year period
• · Nine-month capital expenditures were $61M versus $51M, and depreciation was $73M versus $70M

29-10-2026

Life Time Group Holdings reported Q3 2026 total revenue of $893.5M, up 14.2% YoY from $782.6M, and net income of $106.5M, up 4.0% from $102.4M. Growth was partly offset by sharper cost increases: center operations expenses rose 14.5% and depreciation and amortization rose 13.2%, while diluted EPS grew only 2.2% to $0.46. For the nine months, revenue rose 13.2% to $2,548.2M and net income rose 18.1% to $295.9M, with diluted EPS of $1.30 versus $1.11.

• · Q3 2026 other income was zero versus $22.0M in Q3 2025, which largely explains why pre-tax income grew only 3.3% despite a 16.5% rise in operating income.
• · Q3 2026 provision for income taxes rose 1.3% while pre-tax income rose 3.3%; nine-month effective tax rate rose to about 25.6% from 22.0%.
• · Nine-month capital expenditures rose 38.3% to $812.0M, and free cash flow turned negative at about -$141.6M versus +$43.7M a year earlier, though sale-leaseback proceeds of $262.5M partly funded the outlay.
• · Share repurchases of $73.4M occurred in the nine months of 2026 versus none in the prior-year period, while stock option exercises contributed $63.0M of financing inflows.
• · Nine-month interest expense, net fell 26.8% to $47.8M, supporting earnings growth.
• · Equity in earnings of affiliates swung to a $2.0M loss for the nine months from a $0.2M gain a year earlier.

29-10-2026

Kymera Therapeutics reported a Q3 2026 net loss of $132.0M ($1.32 per share), wider than the $82.2M loss in Q3 2025, as R&D spending rose 73% YoY to $128.5M. The company recorded no collaboration revenue in the quarter versus $2.8M a year earlier, though nine-month collaboration revenue of $99.4M was up from $36.3M. Cash, cash equivalents and marketable securities totaled roughly $1.65B at September 30, 2026, supported by $215.4M of at-the-market equity issuance year to date.

• · Q3 2026 operating loss widened to $147.2M from $92.5M, with no collaboration revenue offsetting expenses
• · Nine-month deferred revenue unwound by $34.4M, with the balance fully recognized by September 30, 2026
• · Unrealized losses on marketable securities of $16.5M for nine months reduced accumulated other comprehensive income to a $14.7M loss
• · Cash used in operating activities rose to $220.8M for nine months from $166.1M, a 33% increase
• · Stockholders' equity rose to $1.61B from $1.58B at year-end 2025, despite the accumulated deficit growing to $1.33B

29-10-2026

West Bancorporation (WTBA) reported Q3 2026 net income of $11.6 million ($0.67 diluted EPS), up 25% from $9.3 million ($0.55) a year earlier, and nine-month net income of $33.3 million ($1.93 diluted EPS), up 32% YoY. Net interest income rose 17% YoY to $26.4 million, driven by lower deposit costs and higher securities-purchased income, while trust services grew 33%. However, comprehensive income turned negative at $(5.7) million for the quarter as unrealized securities losses drove accumulated other comprehensive loss to $(84.0) million, total deposits fell 6% year-to-date, and total assets declined 6% to $3.89 billion since December 2025.

• · Q3 2026 total interest expense fell 14% YoY to $22.8M, with deposit interest expense down 14% to $19.4M
• · FDIC insurance expense fell 29% YoY in Q3 to $455K from $637K
• · Allowance for credit losses held flat at $30.5M with no credit loss expense recorded in either period
• · Salaries and employee benefits rose 7% YoY in Q3 to $8.0M, a partial offset to margin gains
• · Q3 cash dividend of $0.26 per share versus $0.25 a year earlier
• · Securities available for sale declined 11% to $415.6M since December 2025 and FHLB advances were paid down $60.0M